# Madrigal Pharmaceuticals, Inc.: Form SC 13D/A, filed Dec 13, 2023

- Company: [Madrigal Pharmaceuticals, Inc.](/companies/mdgl.md) (CIK 1157601)
- Form: SC 13D/A
- Filed: 2023-12-13
- Accepted by EDGAR: Dec 13, 2023, 16:05 ET
- Period: not reported
- Accession: 0001193125-23-294326
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1157601/000119312523294326/d510843dsc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1157601/000119312523294326/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1157601/000119312523294326/d510843dsc13da.htm

Filed Dec 13, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-294326. Last ingested by Listed: Nov 6, 2026, 18:49 ET. No prices; not investment advice.
